UBS Group’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Buy
212,919
+10,442
+5% +$715K ﹤0.01% 3320
2025
Q4
$14.1M Sell
202,477
-5,615
-3% -$229K ﹤0.01% 2937
2025
Q3
$5.83M Buy
208,092
+55,111
+36% +$1.1M ﹤0.01% 3883
2025
Q2
$3.17M Sell
152,981
-85,216
-36% -$1.87M ﹤0.01% 4340
2025
Q1
$4.12M Sell
238,197
-5,866
-2% -$144K ﹤0.01% 3986
2024
Q4
$6.62M Buy
244,063
+204,983
+525% +$7.27M ﹤0.01% 3519
2024
Q3
$1.72M Buy
39,080
+33,717
+629% +$1.3M ﹤0.01% 4149
2024
Q2
$211K Sell
5,363
-77,351
-94% -$3.18M ﹤0.01% 5624
2024
Q1
$3.55M Buy
82,714
+23,077
+39% +$973K ﹤0.01% 3345
2023
Q4
$2.43M Buy
+59,637
New +$3.42M ﹤0.01% 3596
2023
Q3
Sell
-2
Closed -$83 9646
2023
Q2
$83 Buy
+2
New +$56 ﹤0.01% 8536

Other funds holding GPCR